← Leaderboards
Hani Goodarzi
Rockefeller University
$10,839,586
Attributed
$13,314,435
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,314,435 · 7
By mechanism
R01$12,438,881 · 5
R00$745,916 · 1
K99$129,638 · 1
Top collaborators
- Justin Kawika Ichida4 shared
Most similar at Rockefeller University
Same institution · by research overlap
- Tom W Muir$26,219,526
- Kivanc Birsoy$11,514,216
- Sanford M Simon$20,890,479
- Hachung Chung$2,317,278
- Galadriel Astra Hovel-Miner$2,201,945
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularProgramsCellsBiologyExperimental StudyGenetic TranscriptionMediatingDissectionInsightBindingTranscriptHuman DiseaseComplexIn VivoBaseGene ExpressionGene Expression RegulationPlayEnhancersRegulationRegulatory PathwayRna-Binding ProteinsPathway InteractionsPromoter
Grant awards (30)
Leveraging Natural Phenotypic Variations of Heterogenous ALS Populations-in-a-Dish to Enable Scalable Drug Discovery$1,968,019
R01 · FY2025 · NS
The RNA structural code underlying pathological regulation of RNA splicing in metastasis$360,261
R01 · FY2025 · CA · contact PI
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery$986,054
R01 · FY2024 · NS
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression$382,774
R01 · FY2024 · HG · contact PI
The RNA structural code underlying pathological regulation of RNA splicing in metastasis$342,248
R01 · FY2024 · CA · contact PI
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery$987,822
R01 · FY2023 · NS
An antisense RNA-mediated regulatory program that drives cancer metastasis$417,339
R01 · FY2023 · CA · contact PI
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression$397,807
R01 · FY2023 · HG · contact PI
The RNA structural code underlying pathological regulation of RNA splicing in metastasis$353,057
R01 · FY2023 · CA · contact PI
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery$1,007,803
R01 · FY2022 · NS
An antisense RNA-mediated regulatory program that drives cancer metastasis$417,339
R01 · FY2022 · CA · contact PI
Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression$403,750
R01 · FY2022 · HG · contact PI
The RNA structural code underlying pathological regulation of RNA splicing in metastasis$353,057
R01 · FY2022 · CA · contact PI
An antisense RNA-mediated regulatory program that drives cancer metastasis$425,855
R01 · FY2021 · CA · contact PI
The RNA structural code underlying pathological regulation of RNA splicing in metastasis$360,261
R01 · FY2021 · CA · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$332,850
R01 · FY2021 · GM · contact PI
Single-cell resolution MERSCOPE to localize RNA methylation and intron retention events$175,000
R01 · FY2021 · GM · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$89,505
R01 · FY2021 · GM · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$440,256
R01 · FY2020 · GM · contact PI
An antisense RNA-mediated regulatory program that drives cancer metastasis$425,855
R01 · FY2020 · CA · contact PI
Alzheimer's Administrative Supplement - An antisense RNA-mediated regulatory program that drives cancer metastasis$403,750
R01 · FY2020 · CA · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$17,901
R01 · FY2020 · GM · contact PI
An antisense RNA-mediated regulatory program that drives cancer metastasis$423,218
R01 · FY2019 · CA · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$332,850
R01 · FY2019 · GM · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$332,850
R01 · FY2018 · GM · contact PI
Systematic dissection of an aberrant splicing program driving cancer metastasis$248,297
R00 · FY2018 · CA · contact PI
Targeted regulation of transcript stability through RNA methylation and intron retention$301,400
R01 · FY2017 · GM · contact PI
Systematic dissection of an aberrant splicing program driving cancer metastasis$248,631
R00 · FY2017 · CA · contact PI
Systematic dissection of an aberrant splicing program driving cancer metastasis$248,988
R00 · FY2016 · CA · contact PI
Structural RNA elements and their roles in post-transcriptional regulation$129,638
K99 · FY2015 · CA · contact PI